Financials

  • Market Capitalization 19.01 M
  • Employee 18
  • Founded 2020
  • CEO N/A
  • Website www.tevogen.com
  • Headquarter Delaware, United States
  • FIGI BBG013395405
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.7
ratio cours/chiffre d'affaires
-66.55

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4579
SKYE
Skye Bioscience, Inc. - Common Stock
0.61 USD-1.61%-12.86%-12.86%-23.75%21.44 M USD
4599
CLRB
Cellectar Biosciences, Inc. - Common Stock
2.62 USD-0.38%-6.43%+11.49%-16.56%20.94 M USD
4606
NXTC
NextCure, Inc. - Common Stock
6.58 USD0.00%+269.66%+219.42%-49.77%23.77 M USD
4608
KALA
KALA BIO, Inc. - Common Stock
1.02 USD+6.25%-26.62%-61.94%-81.62%18.96 M USD

Nouvelles